SZSE:300009 (China)
Â
Class A
Â¥
9.93
(+0.81%)
Apr 26
Business Description
Anhui Anke Biotechnology (Group) Co Ltd
NAICS : 325414
SIC : 2836
ISIN : CNE100000GY2
Share Class Description:
SZSE:300009: Class ACompare
Compare
Traded in other countries / regions
300009.China IPO Date
2009-10-30Description
Anhui Anke Biotechnology (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceuticals and health-care products. The Company distributes its product in both domestic and overseas markets. The company operates in more than 30 provinces in China.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 25.71 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.06 | |||||
| Interest Coverage | 515.51 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 11.6 | |||||
| Beneish M-Score | -2.44 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 18.3 | |||||
| 3-Year EBITDA Growth Rate | 27.7 | |||||
| 3-Year EPS without NRI Growth Rate | 35.7 | |||||
| 3-Year FCF Growth Rate | 31.6 | |||||
| 3-Year Book Growth Rate | 8.8 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 61.69 | |||||
| 9-Day RSI | 56.51 | |||||
| 14-Day RSI | 54.33 | |||||
| 6-1 Month Momentum % | -4.08 | |||||
| 12-1 Month Momentum % | -13.23 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.75 | |||||
| Quick Ratio | 2.47 | |||||
| Cash Ratio | 1.72 | |||||
| Days Inventory | 133.68 | |||||
| Days Sales Outstanding | 60.55 | |||||
| Days Payable | 95.68 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.54 | |||||
| Dividend Payout Ratio | 0.47 | |||||
| 3-Year Dividend Growth Rate | 37.6 | |||||
| Forward Dividend Yield % | 2.54 | |||||
| 5-Year Yield-on-Cost % | 9.43 | |||||
| 3-Year Average Share Buyback Ratio | -0.8 | |||||
| Shareholder Yield % | 2.5 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 78.35 | |||||
| Operating Margin % | 33.71 | |||||
| Net Margin % | 29.56 | |||||
| FCF Margin % | 26.44 | |||||
| ROE % | 24.73 | |||||
| ROA % | 18.8 | |||||
| ROIC % | 34.82 | |||||
| ROC (Joel Greenblatt) % | 70.14 | |||||
| ROCE % | 24.27 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.47 | |||||
| PE Ratio without NRI | 18.77 | |||||
| Shiller PE Ratio | 47.29 | |||||
| Price-to-Owner-Earnings | 24.49 | |||||
| PEG Ratio | 0.65 | |||||
| PS Ratio | 5.81 | |||||
| PB Ratio | 4.45 | |||||
| Price-to-Tangible-Book | 5.55 | |||||
| Price-to-Free-Cash-Flow | 21.96 | |||||
| Price-to-Operating-Cash-Flow | 17.54 | |||||
| EV-to-EBIT | 16.4 | |||||
| EV-to-EBITDA | 16.4 | |||||
| EV-to-Revenue | 5.28 | |||||
| EV-to-FCF | 19.78 | |||||
| Price-to-Projected-FCF | 2.25 | |||||
| Price-to-DCF (Earnings Based) | 0.77 | |||||
| Price-to-DCF (FCF Based) | 0.7 | |||||
| Price-to-Median-PS-Value | 0.51 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.75 | |||||
| Price-to-Graham-Number | 2.15 | |||||
| Price-to-Net-Current-Asset-Value | 15.05 | |||||
| Price-to-Net-Cash | 70.93 | |||||
| Earnings Yield (Greenblatt) % | 6.1 | |||||
| FCF Yield % | 4.55 | |||||
| Forward Rate of Return (Yacktman) % | 22.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Anhui Anke Biotechnology (Group) Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,865.752 | ||
| EPS (TTM) (Â¥) | 0.51 | ||
| Beta | 1.38 | ||
| Volatility % | 33.81 | ||
| 14-Day RSI | 54.33 | ||
| 14-Day ATR (Â¥) | 0.306974 | ||
| 20-Day SMA (Â¥) | 9.746 | ||
| 12-1 Month Momentum % | -13.23 | ||
| 52-Week Range (Â¥) | 7.56 - 11.5 | ||
| Shares Outstanding (Mil) | 1,676.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Anhui Anke Biotechnology (Group) Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Anhui Anke Biotechnology (Group) Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Anhui Anke Biotechnology (Group) Co Ltd Frequently Asked Questions
What is Anhui Anke Biotechnology (Group) Co Ltd(SZSE:300009)'s stock price today?
The current price of SZSE:300009 is ¥9.93. The 52 week high of SZSE:300009 is ¥11.50 and 52 week low is ¥7.56.
When is next earnings date of Anhui Anke Biotechnology (Group) Co Ltd(SZSE:300009)?
The next earnings date of Anhui Anke Biotechnology (Group) Co Ltd(SZSE:300009) is .
Does Anhui Anke Biotechnology (Group) Co Ltd(SZSE:300009) pay dividends? If so, how much?
The Dividend Yield %  of Anhui Anke Biotechnology (Group) Co Ltd(SZSE:300009) is 2.54% (As of Today), Highest Dividend Payout Ratio of Anhui Anke Biotechnology (Group) Co Ltd(SZSE:300009) was 1.67. The lowest was 0.31. And the median was 0.48. The  Forward Dividend Yield % of Anhui Anke Biotechnology (Group) Co Ltd(SZSE:300009) is 2.54%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers